We are live on ! Find out more
BIOTW

Biotech Acquisition Company Warrant
BIOTW

Delisted

BIOTW was delisted on the 2nd of February, 2023.

Back to rankings

20 hedge funds and large institutions have $2.08M invested in Biotech Acquisition Company Warrant in 2021 Q1 according to their latest regulatory filings, with 20 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
20
Holders Change
+20
Holders Change %
–
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
–
Reduced
–
Closed
–
Calls
$485K
Puts
–
Net Calls
+$485K
Net Calls Change
+$485K

Top Buyers

Rank Fund Capital Flow
1
CCP
Corbin Capital Partners
New York
+$436K
2
Citadel Advisors
Citadel Advisors
Florida
+$316K
3
MI
MMCAP International
Cayman Islands
+$212K
4
PAMP
Polar Asset Management Partners
Ontario, Canada
+$212K
5
ACM
Atalaya Capital Management
New York
+$196K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
CCP
1
Corbin Capital Partners
New York
$371K +$436K +618,749 New
Citadel Advisors
2
Citadel Advisors
Florida
$273K +$316K +447,817 New
MI
3
MMCAP International
Cayman Islands
$180K +$212K +300,000 New
PAMP
4
Polar Asset Management Partners
Ontario, Canada
$180K +$212K +300,000 New
ACM
5
Atalaya Capital Management
New York
$170K +$196K +278,437 New
Blackstone Inc
6
Blackstone Inc
New York
$150K +$176K +250,000 New
KCM
7
Kingstown Capital Management
New York
$150K +$176K +250,000 New
FTCM
8
Fir Tree Capital Management
New York
$92K +$106K +150,000 New
MP
9
Mangrove Partners
Connecticut
$90K +$106K +150,000 New
SC
10
Sculptor Capital
New York
$86K +$106K +150,000 New
TCM
11
Tenor Capital Management
New York
$84K +$98.9K +140,290 New
CH
12
CVI Holdings
Delaware
$61K +$70.5K +100,000 New
Bank of America
13
Bank of America
North Carolina
$42K +$49.4K +70,071 New
WA
14
Whitebox Advisors
Minnesota
$38K +$44.1K +62,500 New
CP
15
Centerbridge Partners
New York
$30K +$35.3K +50,000 New
Jane Street
16
Jane Street
New York
$30K +$35.3K +50,000 New
CCA
17
Castle Creek Arbitrage
Colorado
$29K +$35.3K +50,000 New
EAM
18
Exos Asset Management
New York
$8K +$8.81K +12,500 New
Goldman Sachs
19
Goldman Sachs
New York
$7K +$7.92K +11,240 New
BCM
20
Basso Capital Management
Connecticut
$6K +$7.58K +10,758 New

BIOTW Hedge Fund Activity: Q1 2021 in Review

20 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Biotech Acquisition Company Warrant (BIOTW) for Q1 2021, worth a combined $2.08M.

Buyers outnumbered sellers: 20 funds opened new BIOTW positions and 0 closed out — a net gain of 20 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Corbin Capital Partners, opening a new position worth an estimated $436K.

  • 20 institutional investors held Biotech Acquisition Company Warrant (BIOTW) as of Q1 2021, up from 0 in Q4 2020.
  • Funds reported $2.08M of Biotech Acquisition Company Warrant stock for Q1 2021.
  • 20 funds opened new Biotech Acquisition Company Warrant positions in Q1 2021 and 0 closed out, a net change of +20 holders.
  • The largest Biotech Acquisition Company Warrant buyer in Q1 2021 was Corbin Capital Partners, an estimated $436K added.

Based on aggregated 13F filings for Q1 2021.